SENSEI BIOTHERAPEUTICS INC's ticker is SNSE and the CUSIP is 81728A108. A total of 25 filers reported holding SENSEI BIOTHERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $138,769 | +62408.6% | 223,785 | +6.1% | 0.00% | – |
| Q1 2024 | $222 | +124.2% | 211,000 | +47.0% | 0.00% | – |
| Q4 2023 | $99 | +47.8% | 143,508 | +71.3% | 0.00% | – |
| Q3 2023 | $67 | -34.3% | 83,800 | -6.4% | 0.00% | – |
| Q2 2023 | $102 | -45.7% | 89,500 | -28.5% | 0.00% | – |
| Q1 2023 | $188 | -26.8% | 125,200 | -27.4% | 0.00% | – |
| Q4 2022 | $257 | -99.9% | 172,554 | -16.2% | 0.00% | – |
| Q3 2022 | $319,000 | -43.1% | 205,800 | -16.7% | 0.00% | -100.0% |
| Q2 2022 | $561,000 | +192.2% | 247,000 | +196.9% | 0.00% | – |
| Q1 2022 | $192,000 | – | 83,195 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 650,000 | $403,065 | 0.07% |
| Deuterium Capital Management, LLC | 11,000 | $6,821 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 172,835 | $107,175 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 77,900 | $48,306 | 0.00% |
| XTX Topco Ltd | 14,047 | $8,711 | 0.00% |
| Leo Wealth, LLC | 14,845 | $9,205 | 0.00% |
| NORTHERN TRUST CORP | 25,983 | $16,112 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| Cresset Asset Management, LLC | 19,671 | $12,198 | 0.00% |
| Banque Cantonale Vaudoise | 3,900 | $2 | 0.00% |